NCT01935011

Brief Summary

The stimulation frequency has been found to affect the axial symptoms of freezing of gait (FOG) and speech in advanced Parkinson's disease (PD) patients with subthalamic nucleus deep brain stimulation (STN DBS), with the traditionally high stimulation frequency of 130 Hz worsening while low frequency of 60 Hz improving these symptoms. The effect of stimulation frequency on another important axial symptom, swallowing dysfunction, has not been studied. The investigators hypothesize that stimulation frequency could have similar effect on swallowing function.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
7

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Aug 2013

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 1, 2013

Completed
26 days until next milestone

First Submitted

Initial submission to the registry

August 27, 2013

Completed
8 days until next milestone

First Posted

Study publicly available on registry

September 4, 2013

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2014

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2014

Completed
Last Updated

April 28, 2015

Status Verified

April 1, 2015

Enrollment Period

11 months

First QC Date

August 27, 2013

Last Update Submit

April 27, 2015

Conditions

Outcome Measures

Primary Outcomes (1)

  • The primary outcome would be the OPMS swallowing function scores

    Eight PD patients with STN DBS and FOG responsive to stimulation frequency changes will be enrolled. Information on the oropharyngeal motility study (OPMS) of the oral, pharyngeal and esophageal phase function will be collected, under "Med on/DBS off", "Med on/DBS 130 Hz", or "Med on/DBS 60 Hz". Each patient will be randomly assigned to these three conditions in a double blinded manner of 30 minutes apart. The patients will be reassessed under the single best condition (likely Med on/DBS 60 Hz) after being on for 6-8 weeks. ANOVA will be used for group comparison of the scores. A regression model will be further used to assess the predicting value (s) of the other scores and demographics for the swallowing function.

    One year

Secondary Outcomes (4)

  • The secondary outcome would be the swallowing questionnaire score

    One year

  • The secondary outcome would also be the unified PD rating scale

    One year

  • The secondary outcome would be the FOG questionnaire score

    One year

  • The secondary outcome would be the standing-walking-sitting test score

    One year

Study Arms (1)

PD DBS 60 Hz, 130 Hz or DBS off

PD DBS on 60 Hz stimulation, 130 Hz stimulation or DBS off

Other: PD, DBS

Interventions

PD, DBSOTHER

PD DBS frequency on swallowing function

PD DBS 60 Hz, 130 Hz or DBS off

Eligibility Criteria

Age45 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Eight PD patients with STN DBS and freezing of gait responsive to stimulation frequency changes will be enrolled.

You may qualify if:

  • Eight PD patients with STN DBS and freezing of gait responsive to stimulation frequency changes will be enrolled.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Chicago

Chicago, Illinois, 60637, United States

Location

MeSH Terms

Conditions

Parkinson Disease

Condition Hierarchy (Ancestors)

Parkinsonian DisordersBasal Ganglia DiseasesBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesMovement DisordersSynucleinopathiesNeurodegenerative Diseases

Study Officials

  • Tao Xie, MD PhD

    University of Chicago

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 27, 2013

First Posted

September 4, 2013

Study Start

August 1, 2013

Primary Completion

July 1, 2014

Study Completion

July 1, 2014

Last Updated

April 28, 2015

Record last verified: 2015-04

Locations